Three different advanced oxidation processes (AOPs) were applied to investigate the removal of emerging contaminants (ECs) i.e. sulfamethoxazole (SMX), diclofenac (DCF) and carbamazepine (CBZ) in synthetically prepared aqueous solutions. The degradation of these substances was carried out by ozonation, sonolysis and photocatalytic oxidation, as well as by different combinations of these processes. The objectives of… Continue reading Removal of emerging contaminants in wastewater by sonolysis, photocatalysis and ozonation
In search of new options to achieve removal of pharmaceuticals in the environment, combined ultrasound and ozonation has become a focus of intense investigation for wastewater treatment. In this study, three pharmaceuticals were selected as model compounds for degradation experiments: diclofenac (DCF), sulfamethoxazole (SMX) and carbamazepine (CBZ). Comparison of the degradation rates for both ozonation… Continue reading Enhanced ozonation of selected pharmaceutical compounds by sonolysis
The occurrence and fate of pharmaceuticals in the environment, and in aquatic media in particular, have received considerable attention by the scientific community during the last two decades. Pharmaceuticals, which are designed to be biologically active substances, are usually lipophilic and resistant to biodegradation, thus having the potential for accumulation and persistence in the environment.… Continue reading Sonochemical degradation of twenty-three emerging contaminants in urban wastewater
Diclofenac is a widely used anti-inflammatory non-steroidal drug that escapes conventional urban wastewater treatment trains because of its resistance to biodegradation. Therefore it is frequently found in treated effluents, lakes and rivers. It has been reported that diclofenac can exhibit adverse effects on aquatic organisms. Advanced oxidation processes like ozonation (O3) and sonolysis (US) can… Continue reading Degradation of diclofenac during sonolysis, ozonation and their simultaneous application
